Ingrid Oakley‐Girvan

ORCID: 0000-0003-0328-921X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mobile Health and mHealth Applications
  • Cancer survivorship and care
  • Palliative Care and End-of-Life Issues
  • Genetic Associations and Epidemiology
  • Digital Mental Health Interventions
  • Patient-Provider Communication in Healthcare
  • Prostate Cancer Treatment and Research
  • Global Cancer Incidence and Screening
  • Health Literacy and Information Accessibility
  • BRCA gene mutations in cancer
  • Childhood Cancer Survivors' Quality of Life
  • Family Support in Illness
  • Ovarian cancer diagnosis and treatment
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Prostate Cancer Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Patient Satisfaction in Healthcare
  • Electronic Health Records Systems
  • Complementary and Alternative Medicine Studies
  • Ethics in Clinical Research
  • Obesity, Physical Activity, Diet
  • Cancer-related cognitive impairment studies
  • Head and Neck Cancer Studies
  • Cardiovascular Health and Risk Factors
  • Cancer Risks and Factors

Public Health Institute
2018-2025

Albemarle (United States)
2020-2025

Cancer Prevention Institute of California
2010-2020

Stanford University
2003-2019

Palo Alto University
2018

Castleton University
2018

Stanford Cancer Institute
2012-2016

John Wiley & Sons (United States)
2016

San Francisco General Hospital
2014

National Institutes of Health
2014

A whole-genome admixture scan in 1,597 African Americans identified a 3.8 Mb interval on chromosome 8q24 as significantly associated with susceptibility to prostate cancer [logarithm of odds (LOD) = 7.1]. The increased risk because inheriting ancestry is greater men diagnosed before 72 years age (P < 0.00032) and may contribute the epidemiological observation that higher for greatest younger (and attenuates older age). same region was recently through linkage analysis cancer, followed by...

10.1073/pnas.0605832103 article EN Proceedings of the National Academy of Sciences 2006-09-01

We assessed cancer survivors' perceptions of the quality their follow-up care.We surveyed a population-based cohort leukemia, bladder, and colorectal survivors diagnosed 2 to 5 years previously in northern California (N = 623; participation rate, 69.2%; overall response 49.2%). Data were collected between April 2003 November 2004. Ten scales different aspects care last 12 months, an eleventh scale measured ratings care.On nine 11 scales, mean scores ranged from 88 97 on 0 100 format,...

10.1200/jco.2010.32.1554 article EN Journal of Clinical Oncology 2011-03-01

BACKGROUND Recent changes in head and neck cancer epidemiology have created a need for improved lymph node prognostics. This article compares the prognostic value of number positive nodes (pN) with ratio (LNR) American Joint Committee on Cancer (AJCC) N staging surgical patients. METHODS The Surveillance, Epidemiology, End Results database was used to identify cases squamous cell carcinomas from 2004 2012. sample grouped by AJCC stage, LNR, pN analyzed Kaplan‐Meier multivariate Cox...

10.1002/cncr.29932 article EN Cancer 2016-03-11

We examined racial and ethnic disparities in patient-provider communication (PPC), perceived care quality, patient activation among long-term cancer survivors.In 2005 to 2006, survivors of breast, prostate, colorectal, ovarian, endometrial cancers completed a mailed survey on follow-up care. African American, Asian/Pacific Islander (Asian), Hispanic, non-Hispanic white (white) who had seen physician for the past 2 years (n = 1,196) composed analytic sample. conducted linear logistic...

10.1200/jco.2014.55.5060 article EN Journal of Clinical Oncology 2014-11-18

Women with mutations of the genes BRCA1 or BRCA2 are at increased risk ovarian cancer. Oral contraceptives protect against cancer in general, but it is not known whether they disease carriers these mutations. We obtained self-reported lifetime histories oral contraceptive use from 451 women who carried BRCA2. used conditional logistic regression to estimate odds ratios associated use, comparing 147 (cases) those 304 without (controls) were matched cases on year birth, country residence and...

10.1038/sj.bjc.6602239 article EN cc-by-nc-sa British Journal of Cancer 2004-11-01

10.1086/432377 article EN publisher-specific-oa The American Journal of Human Genetics 2005-07-08

Abstract Objective Ten years after diagnosis, women diagnosed with breast cancer at age 50 or younger were assessed to determine whether quality of life (QOL) problems found five persisted. We predicted that QOL in the physical and social domains would be poorer, but improvements psychological domain. Methods re‐interviewed 312 women, who had been interviewed their year anniversary remained free, on three (physical, social, psychological). Comparisons between 5‐ 10‐year reports performed...

10.1002/pon.1965 article EN Psycho-Oncology 2011-05-02

Thyroid cancer incidence is increasing worldwide. Incorporating 22 years of data through 2009, we extend examination these trends among a wide array subgroups defined by patient (age, sex, race/ethnicity, and nativity), tumor (tumor size stage), neighborhood (socioeconomic status residence in ethnic enclaves) characteristics, to identify possible reasons for this increase.

10.1158/1055-9965.epi-13-1089 article EN Cancer Epidemiology Biomarkers & Prevention 2014-05-20

We aimed to determine if resting state functional magnetic resonance imaging (fMRI) acquired at pre-treatment baseline could accurately predict breast cancer-related cognitive impairment long-term follow-up. evaluated 31 patients with cancer (age 34-65) prior any treatment, post-chemotherapy and 1 year later. Cognitive testing scores were normalized based on data obtained from 43 healthy female controls then used categorize as impaired or not longitudinal changes. measured clustering...

10.3389/fnhum.2017.00555 article EN cc-by Frontiers in Human Neuroscience 2017-11-15

Abstract Background Deployment of remote and virtual clinical trial methods technologies, referred to collectively as decentralized trials (DCTs), represents a profound shift in practice. To our knowledge, comprehensive assessment the financial net benefits DCTs has not been conducted. Methods We developed an expected present value (eNPV) model cash flows for new drug development commercialization assess impact DCTs. The measure DCT is increment eNPV that occurs, on average, when are...

10.1007/s43441-022-00454-5 article EN cc-by Therapeutic Innovation & Regulatory Science 2022-09-14

A total of 283 epithelial ovarian cancer families from the United Kingdom (UK) and States (US) were screened for coding sequence changes large genomic alterations (rearrangements deletions) in BRCA1 BRCA2 genes. Deleterious mutations identified 104 (37%) 25 (9%). Of mutations, 12 alterations; thus this type change represented 12% all mutations. Six carried a previously described exon 13 duplication, known to be UK founder mutation. The remaining six unreported comprised five deletions an...

10.1002/humu.20599 article EN Human Mutation 2007-08-09

Studies of the histopathology ovarian cancer arising in patients with germline mutations BRCA1 or BRCA2 have shown inconsistent findings. We analyzed large number tumors from women enrolled Gilda Radner Familial Ovarian Cancer Registry for correlations between and BRCA mutation status. Histopathology slides reports were reviewed histology, grade, stage cancers ovary peritoneum 220 126 families. At least one affected member each family was genes, mutation-positive families compared those...

10.1097/01.pgp.0000101083.35393.cd article EN International Journal of Gynecological Pathology 2003-12-11

Introduction: Wearable technologies can enhance measurements completed from home by participants in decentralized clinical trials. These have shown promise monitoring patient wellness outside the setting. However, there are challenges handling data and its interpretation when using consumer wearables, requiring input statisticians scientists. This article describes three methods to estimate daily steps address gaps Apple Watch cancer patients uses one of these an analysis association between...

10.1159/000543898 article EN cc-by-nc Digital Biomarkers 2025-02-03
Coming Soon ...